Newsroom

News

To ensure that vaccines provide strong and lasting immunization, it is often necessary to supplement the actual vaccine (antigen) with additives that stimulate the immune system: adjuvants. Today, only a few substances have been approved for use as adjuvants. In the journal Angewandte Chemie, a research team has now introduced a spectrum of potential adjuvants. They started with the immune stimulant α-glactosyl ceramide (α-GalCer) and synthesized many different variants from a set of four building blocks.

04.12.2023

HZI Campus

News

The Federal Ministry of Education and Research (BMBF) is funding the establishment of a German-Ukrainian core of excellence to help discover new anti-infectives and make them available for medical purposes. The core of excellence, funded with 2.5 million euros, is to be located in the western Ukrainian city of Lviv - in collaboration with Saarland University and the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS). In the long term, the core of excellence should establish itself as an independent research institution and strengthen scientific relations between Germany and Ukraine. The HIPS is a site of the Helmholtz Centre for Infection Research (HZI) in cooperation with Saarland University.

28.11.2023

HIPS

AI Image symbolique, personne en blouse blanche avec stéthoscope en arrière-plan

News

Improving health care and strengthening personalized medicine: A new research center for Artificial Intelligence (AI) and causal methods in medicine (CAIMed - Lower Saxony Center for Artificial Intelligence and Causal Methods in Medicine) is being established in Lower Saxony. Researchers in computer science and medicine from Hannover, Göttingen and Braunschweig will develop innovative methods and applications of artificial intelligence. The Ministry of Science and Culture and the Volkswagen Foundation are providing 15 million euros from the joint "zukunft.niedersachsen" program for the next five years. Prof Wolfgang Nejdl from the L3S Research Centre at the Leibniz University of Hanover (LUH) will act as spokesperson. Two of the new research groups will be set up at sites of the Helmholtz Centre for Infection Research (HZI).

22.11.2023

HZI Campus

CiiM

BRICS

News

The list of “Highly-cited researchers” is published annually by Clarivate Analytics to honor scientists who have made a particularly significant impact in their fields. Five heads of department at the Helmholtz Centre for Infection Research (HZI) are among the honorees in 2023: bioinformaticians Prof Alice McHardy, Prof Yang Li and Prof Andreas Keller, biotechnologist Prof Marc Stadler and the Scientific Director of the HZI and geneticist Prof Josef Penninger were recognized for their scientific publications in the past year.

17.11.2023

BRICS

CiiM

HZI Campus

HIPS

News

Sustainable and environmentally friendly production processes are playing an increasingly important role in almost all branches of industry. The production of active pharmaceutical ingredients in particular involves the use of various materials and reagents, many of which have environmentally harmful properties and therefore require costly processing and disposal. Researchers at the University of Graz and the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS) have now succeeded in developing a strategy for the synthesis of active pharmaceutical ingredients from wood waste that does not involve any harmful starting materials or by-products. The team published its results in the journal Angewandte Chemie International Edition.

16.11.2023

HIPS

Picture of the current DZIF Executive Board

News

Professor Thomas Pietschmann, Scientific Co-Director of the Helmholtz Centre for Infection Research (HZI), Professor of Experimental Virology at Hannover Medical School (MHH) and virologist at TWINCORE - Centre for Experimental and Clinical Infection Research—a joint institution of the MHH and the HZI—has been elected to the DZIF Executive Board by the members of the German Center for Infection Research (DZIF). Pietschmann's term of office begins on 8 November 2023.

09.11.2023

TWINCORE

HZI Campus

Back to the first page
...
22
23
24
25
...
132

HZI in the media

... Brinkmann (Archivbild): Die Virologin forscht am Helmholtz-Zentrum für Infektionsforschung in Braunschweig. (Quelle: teutopress/ ...

11.07.2025

t-online.de

... des HZI, der Technischen Universität Braunschweig und des Fördervereins des HZI.

Promotionspreise des HZI

Der ...

11.07.2025

Regional Heute

... lassen. Ein weiterer Partner ist das Helmholtz-Zentrum für Infektionsforschung (HZI) in Braunschweig. Finanziert wird das ...

07.07.2025

MDR

... Pneumologie an der UMMD sowie dem Helmholtz-Zentrum für Infektionsforschung (HZI) in Braunschweig. Gefährliche Folgeinfektion mit ...

06.07.2025

Magdeburger News

... von der Abteilung Mikrobielle Immunregulation am Helmholtz-Zentrum für Infektionsforschung (HZI) in einer Pressemitteilung des ...

04.07.2025

Pharmazeutische Zeitung

In a groundbreaking new study, researchers from the Helmholtz Center for Infection Research (HZI) and Hannover Medical School (MHH) have

04.07.2025

Maldankon

removed from the gut?

Researchers from the Helmholtz Center for Infection Research (HZI), in collaboration with researchers from Hannover

03.07.2025

Phys.org

Würzburg – Eine Arbeitsgruppe des Würzburger Helmholtz-Instituts für RNA-basierte Infektionsforschung (HIRI) sowie aus Schweden und ...

03.07.2025

Deutsches Ärzteblatt

An international research team led by the Helmholtz Center for Infection Research (HZI) has discovered a new strategy used by the human

02.07.2025

MSN.com

Register now for the HZI-Newsletter

and stay up to date!

Email address

We use rapidmail to send our newsletter. I agree that my data entered here will be transmitted to rapidmail. I have taken note of the HZI's privacy policy and have been informed of my rights.

Please enter here the word as displayed in the picture. This is to prevent spamming.*

If you can't read the word, click here.